Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCoronary stents

    Coronary Stents

    Jump to

    • Under cost pressure, Abbott to urge NPPA to allow withdrawal of stents again

      Last week, Indian drug regulator NPPA rejected applications filed by Abbott and Medtronics to withdraw their stent products from market technical grounds.

    • Capped stent prices include 8% trade margin, says regulator

      Data put out earlier by NPPA pointed out that distributors had trade margins between 13 and 196 percent for sale of stents to hospitals, while hospitals enjoyed a margin between 11 percent and 650 percent on sales to patients.

    • NPPA asks stent makers, importers to submit price list by Mar 1

      The national drug pricing regulator NPPA has asked manufacturers and importers of coronary stents to submit details, including price list of their products, before March 1.

    • Govt to act against cos creating artificial shortage of stents

      Government today said it is keeping a close watch on some companies trying to create an artificial shortage of life-saving coronary stents and stringent action will taken against those engaging in unethical practices.

    • ADEH asks Govt to review pricing of coronary stents

      Expressing serious concern over affordability in health care, a network of doctors today asked the Centre to review pricing of coronary stents to stop the device industry from making "huge" profits.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347